ask="0.558"
ask_size="1900"
average_daily_volume="986620"
bid="0.530"
bid_size="7500"
book_value="-0.153"
change="-0.028"
change_from_200_day_moving_average="0.084"
change_from_50_day_moving_average="0.057"
change_from_52_week_high="-1.005"
change_From_52_week_low="0.337"
change_in_percent="-5.046%"
close="0.525"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.654"
ebitda="-18.11M"
eps_estimate_current_year="-0.550"
eps_estimate_next_quarter="-0.090"
eps_estimate_next_year="-0.450"
ex_dividend_date="N/A"
float_shares="47744000"
high="0.580"
high_52_weeks="1.530"
last_trade_date="3/17/2017"
last_trade_price="0.525"
last_trade_size="14752"
last_trade_time="4:02pm"
low="0.512"
low_52_weeks="0.188"
market_capitalization="35.55M"
moving_average_200_day="0.441"
moving_average_50_day="0.468"
name="BioPharmX Corporation. Common"
notes="N/A"
one_year_target_price="3.000"
open="0.570"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+19.042%"
percent_change_from_50_day_moving_average="+12.207%"
percent_change_from_52_week_high="-65.686%"
percent_change_from_52_week_low="+178.810%"
previous_close="0.553"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="312.018"
revenue="119999.00"
shares_outstanding="67719000"
short_ratio="2.010"
stock_exchange="ASE"
symbol="BPMX"
volume="1431019"
weeks_range_52="0.188 - 1.530"
